Infertility,Female
6
2
2
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Impact of FSH Dosage During Ovarian Stimulation for IVF/ICSI in Granulosa Cells
Social Egg Freezing: Will Health Professionals Offer it ?
The Role of Granulocyte Colony Stimulating Factor in Embryo Transfer Outcomes
Growth Hormone Adding to Controlled Ovarian Hyperstimulation for Improving Embryo Quality
Recombinant LH Supplementation Timing Strategies (From Day 1 or Day 6) to a Standard GnRH Agonist Long Protocol in Subsequent COS Cycle of Older Patients With Unexpected Poor or Suboptimal Ovarian Response
G-CSF and PRP in Patients With Recurrent Implantation Failure